• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙调蛋白与乳腺癌细胞中死亡受体5介导的死亡诱导信号复合物的结合

Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.

作者信息

Fancy Romone M, Kim Harrison, Zhou Tong, Zinn Kurt R, Buchsbaum Donald J, Song Yuhua

机构信息

Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham 35294, Alabama.

Department of Radiology, The University of Alabama at Birmingham, Birmingham 35294, Alabama.

出版信息

J Cell Biochem. 2017 Aug;118(8):2285-2294. doi: 10.1002/jcb.25882. Epub 2017 Apr 12.

DOI:10.1002/jcb.25882
PMID:28092099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5462859/
Abstract

Activation of death receptor-5 (DR5) leads to the formation of death-inducing signaling complex (DISC) for apoptotic signaling. TRA-8, a DR5 specific agonistic antibody, has demonstrated significant cytotoxic activity in vitro and in vivo without inducing hepatotoxicity. Calmodulin (CaM) that is overexpressed in breast cancer plays a critical role in regulating DR5-mediated apoptosis. However, the mechanism of CaM in regulating DR5-mediated apoptotic signaling remains unknown. In this study, we characterized CaM binding to DR5-mediated DISC for apoptosis in TRA-8 sensitive breast cancer cell lines using co-immunoprecipitation, fluorescence microscopic imaging, caspase signaling analysis, and cell viability assay. Results show that upon DR5 activation, CaM was recruited into DR5-mediated DISC in a calcium dependent manner. CaM antagonist, trifluoperazine (TFP), inhibited CaM recruitment into the DISC and attenuated DISC formation. DR5 oligomerization is critical for DISC formation for apoptosis. TFP decreased TRA-8 activated DR5 oligomerization, which was consistent with TFP's effect on DR5-mediated DISC formation. TFP and Ca chelator, EGTA, impeded TRA-8-activated caspase-dependent apoptotic signaling, and TFP decreased TRA-8-induced cell cytotoxicity. These results demonstrated CaM binding to DR5-mediated DISC in a calcium dependent manner and may identify CaM as a key regulator of DR5-mediated DISC formation for apoptosis in breast cancer. J. Cell. Biochem. 118: 2285-2294, 2017. © 2017 Wiley Periodicals, Inc.

摘要

死亡受体-5(DR5)的激活会导致凋亡信号转导的死亡诱导信号复合物(DISC)的形成。TRA-8是一种DR5特异性激动抗体,已在体外和体内显示出显著的细胞毒活性,且不会诱导肝毒性。在乳腺癌中过表达的钙调蛋白(CaM)在调节DR5介导的凋亡中起关键作用。然而,CaM调节DR5介导的凋亡信号转导的机制仍不清楚。在本研究中,我们使用免疫共沉淀、荧光显微镜成像、半胱天冬酶信号分析和细胞活力测定,对CaM与TRA-8敏感的乳腺癌细胞系中DR5介导的凋亡DISC的结合进行了表征。结果表明,在DR5激活后,CaM以钙依赖的方式被募集到DR5介导的DISC中。CaM拮抗剂三氟拉嗪(TFP)抑制CaM募集到DISC中并减弱DISC的形成。DR5寡聚化对于凋亡的DISC形成至关重要。TFP降低了TRA-8激活的DR5寡聚化,这与TFP对DR5介导的DISC形成的影响一致。TFP和钙螯合剂乙二醇双四乙酸(EGTA)阻碍了TRA-8激活的半胱天冬酶依赖性凋亡信号转导,并且TFP降低了TRA-8诱导的细胞毒性。这些结果表明CaM以钙依赖的方式与DR5介导的DISC结合,并可能确定CaM是乳腺癌中DR5介导的凋亡DISC形成的关键调节因子。《细胞生物化学杂志》118:2285 - 2294,2017年。©2017威利期刊公司

相似文献

1
Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.钙调蛋白与乳腺癌细胞中死亡受体5介导的死亡诱导信号复合物的结合
J Cell Biochem. 2017 Aug;118(8):2285-2294. doi: 10.1002/jcb.25882. Epub 2017 Apr 12.
2
Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.钙调蛋白拮抗剂可促进TR-8对耐药性胰腺癌的治疗。
Oncotarget. 2015 Sep 22;6(28):25308-19. doi: 10.18632/oncotarget.4490.
3
Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells.钙调蛋白拮抗剂增强 TRA-8 耐药三阴性乳腺癌细胞中 DR5 介导的凋亡信号。
J Cell Biochem. 2018 Jul;119(7):6216-6230. doi: 10.1002/jcb.26848. Epub 2018 Apr 16.
4
Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells.钙调蛋白与胆管癌细胞中Fas介导的死亡诱导信号复合物的结合。
J Cell Biochem. 2008 Feb 15;103(3):788-99. doi: 10.1002/jcb.21447.
5
Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.三阴性和雌激素受体阳性乳腺癌细胞中钙调蛋白与死亡受体5相互作用的表征:一项综合实验与计算研究
J Biol Chem. 2016 Jun 10;291(24):12862-12870. doi: 10.1074/jbc.M116.727727. Epub 2016 Apr 22.
6
TRAIL enhances quinacrine-mediated apoptosis in breast cancer cells through induction of autophagy via modulation of p21 and DR5 interactions.TRAIL 通过调节 p21 和 DR5 的相互作用诱导自噬增强了奎纳克林介导的乳腺癌细胞凋亡。
Cell Oncol (Dordr). 2017 Dec;40(6):593-607. doi: 10.1007/s13402-017-0347-3. Epub 2017 Sep 21.
7
Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study.DR5死亡结构域突变在死亡诱导信号复合物形成中对DR5死亡结构域-FADD复合物寡聚化作用的结构洞察:一项计算研究
J Mol Model. 2016 Apr;22(4):89. doi: 10.1007/s00894-016-2941-0. Epub 2016 Mar 19.
8
5-Fluorouracil signaling through a calcium-calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells.5-氟尿嘧啶通过钙调蛋白依赖的途径发挥信号作用,对于结肠癌细胞中 p53 的激活和凋亡是必需的。
Oncogene. 2013 Sep 19;32(38):4529-38. doi: 10.1038/onc.2012.467. Epub 2012 Oct 29.
9
Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5.调控 TRAIL 抵抗在结肠癌细胞中的作用:DR4 和 DR5 的不同作用。
BMC Cancer. 2011 Jan 27;11:39. doi: 10.1186/1471-2407-11-39.
10
Trifluoperazine regulation of calmodulin binding to Fas: a computational study.三氟拉嗪对钙调蛋白与 Fas 结合的调节:一项计算研究。
Proteins. 2011 Aug;79(8):2543-56. doi: 10.1002/prot.23081. Epub 2011 Jun 7.

引用本文的文献

1
TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling.肿瘤坏死因子相关凋亡诱导配体:非凋亡信号。
Cells. 2024 Mar 16;13(6):521. doi: 10.3390/cells13060521.
2
From GWAS to drug screening: repurposing antipsychotics for glioblastoma.从 GWAS 到药物筛选:重新利用抗精神病药治疗神经胶质瘤。
J Transl Med. 2022 Feb 4;20(1):70. doi: 10.1186/s12967-021-03209-2.
3
First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer.首个人体 DR5 PET 研究显示胃肠道癌患者的 DR5 表达不足。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002926.
4
Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.通过整合生物信息学分析筛选和鉴定黑色素瘤潜在的生物标志物和治疗药物。
Invest New Drugs. 2021 Aug;39(4):928-948. doi: 10.1007/s10637-021-01072-y. Epub 2021 Jan 26.
5
Defined factors to reactivate cell cycle activity in adult mouse cardiomyocytes.定义在成年小鼠心肌细胞中重新激活细胞周期活性的因素。
Sci Rep. 2019 Dec 11;9(1):18830. doi: 10.1038/s41598-019-55027-8.
6
Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells.钙调蛋白拮抗剂增强 TRA-8 耐药三阴性乳腺癌细胞中 DR5 介导的凋亡信号。
J Cell Biochem. 2018 Jul;119(7):6216-6230. doi: 10.1002/jcb.26848. Epub 2018 Apr 16.

本文引用的文献

1
Characterization of the interactions between calmodulin and death receptor 5 in triple-negative and estrogen receptor-positive breast cancer cells. AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.三阴性和雌激素受体阳性乳腺癌细胞中钙调蛋白与死亡受体5相互作用的表征:一项综合实验与计算研究
J Biol Chem. 2016 Nov 4;291(45):23489. doi: 10.1074/jbc.A116.727727.
2
Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.三阴性和雌激素受体阳性乳腺癌细胞中钙调蛋白与死亡受体5相互作用的表征:一项综合实验与计算研究
J Biol Chem. 2016 Jun 10;291(24):12862-12870. doi: 10.1074/jbc.M116.727727. Epub 2016 Apr 22.
3
Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study.DR5死亡结构域突变在死亡诱导信号复合物形成中对DR5死亡结构域-FADD复合物寡聚化作用的结构洞察:一项计算研究
J Mol Model. 2016 Apr;22(4):89. doi: 10.1007/s00894-016-2941-0. Epub 2016 Mar 19.
4
A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models.从TRA-8/DR5寡聚体荧光显微镜成像中提取的一种新型成像生物标志物可预测TRA-8在乳腺癌和胰腺癌小鼠模型中的治疗效果。
Mol Imaging Biol. 2016 Jun;18(3):325-33. doi: 10.1007/s11307-015-0913-x.
5
Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.钙调蛋白拮抗剂可促进TR-8对耐药性胰腺癌的治疗。
Oncotarget. 2015 Sep 22;6(28):25308-19. doi: 10.18632/oncotarget.4490.
6
Detection of Fas-associated death domain and its variants' self-association by fluorescence resonance energy transfer in living cells.应用荧光共振能量转移技术在活细胞中检测 Fas 相关死亡结构域及其变体的自聚集。
Mol Imaging. 2013 Mar-Apr;12(2):111-20.
7
Breast cancer statistics, 2011.乳腺癌统计数据,2011 年。
CA Cancer J Clin. 2011 Nov-Dec;61(6):409-18. doi: 10.3322/caac.20134. Epub 2011 Oct 3.
8
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.抗 DR5 和化疗对基底样乳腺癌的影响。
Breast Cancer Res Treat. 2012 Jun;133(2):417-26. doi: 10.1007/s10549-011-1755-0. Epub 2011 Sep 7.
9
Trifluoperazine regulation of calmodulin binding to Fas: a computational study.三氟拉嗪对钙调蛋白与 Fas 结合的调节:一项计算研究。
Proteins. 2011 Aug;79(8):2543-56. doi: 10.1002/prot.23081. Epub 2011 Jun 7.
10
Calmodulin mediates Fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-extracellular signal-regulated kinase (ERK).钙调蛋白通过激活Src-细胞外信号调节激酶(ERK)介导 Fas 诱导的胰腺癌细胞中 FADD 非依赖性存活信号。
J Biol Chem. 2011 Jul 15;286(28):24776-84. doi: 10.1074/jbc.M110.202804. Epub 2011 May 25.